{
  "id": 3760717,
  "title": "Moderna's $2B offering; AstraZeneca-Amgen and Biokin chalk up Phase 3 wins",
  "url": "https://urgent.news/2026/08/27/modernas-2b-offering-astrazeneca-amgen-and-biokin-chalk-up-phase-3",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-08-27T14:59:41.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/modernas-2b-offering-astrazeneca-amgen-and-biokin-chalk-up-phase-3-wins/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Takeda China and ProFound. Moderna's $2B offering: The mRNA biotech will offer convertible senior notes for the \"flexibility to invest\" in growing its oncology business and repay debt ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}